Company Overview - LivaNova demonstrates strong and durable growth in its core businesses, which include neuromodulation for epilepsy treatment and cardiopulmonary solutions [1][2] - The company has a diversified portfolio that positions it well in its respective markets [1] Market Expansion Strategy - LivaNova aims to expand into markets with significant unmet patient needs, focusing on high-growth areas where it has competitive advantages [2] - The neuromodulation sector is identified as a key opportunity for future growth [2]